Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2015-04-27 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
第八届监事会第六次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Zhongyuan Xiehe Cell Gene Engineering Co., Ltd. It discusses the review and approval of several reports including the 2014 Annual Report, 2014 Supervisory Board Work Report, 2014 Financial Final Report, 2015 Financial Budget Report, 2014 Profit Distribution Plan, a special report on the use of raised funds, the 2014 Internal Control Evaluation Report, and the 2015 First Quarter Report. However, the document itself does not contain the full reports but rather states that the full reports are available on the Shanghai Stock Exchange website. The document is relatively short (1898 characters) and serves as an official announcement of the Supervisory Board's resolutions and approvals, not the reports themselves. According to the "Menu vs Meal" rule, this is an announcement of report approvals and resolutions, not the reports themselves. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other specific categories and is not the full report itself.
2015-04-27 Chinese
关于公司募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the company's fundraising activities, specifically focusing on the management, storage, and actual use of raised funds. It includes financial figures related to the amount raised, usage, balances, and compliance with regulatory requirements. The document also contains audit opinions and a special verification report from the sponsoring institution regarding the use of the funds. The presence of terms like "募集资金" (fundraising), "募集资金使用情况" (use of raised funds), and references to regulatory approvals and audit reports indicates this is a specialized report on capital raising and fund usage. It is not a general annual or quarterly report, nor is it an announcement or a brief summary. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length and detail confirm it is the report itself, not just an announcement of a report.
2015-04-27 Chinese
第八届董事会第十九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from 中源协和细胞基因工程股份有限公司 dated April 28, 2015. It details the approval of several reports and plans including the 2014 Annual Report, 2014 Board Work Report, 2015 Business Plan, 2014 Financial Statements, 2015 Financial Budget, 2014 Profit Distribution Proposal, and the 2014 Internal Control Evaluation Report. It also mentions the reappointment of the audit firm for 2015 and the approval of the 2015 Q1 report. The document repeatedly states that these approvals are subject to the 2014 Annual General Meeting's review and that the full reports are available on the Shanghai Stock Exchange website. The document itself does not contain the full reports or detailed financial data but is a formal announcement of board resolutions and meeting decisions. Given the nature of the content—board meeting resolutions approving reports and plans—and the absence of full financial statements or detailed analysis, this document fits best under Board/Management Information (MANG).
2015-04-27 Chinese
重大事项停牌公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the suspension of trading (停牌公告) due to the company planning a significant matter. It states the stock will be suspended from April 27, 2015, and that the company will announce progress within 5 trading days. There is no financial data, no report attached or referenced beyond the suspension notice, and no detailed financial or management information. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about trading suspension and planned significant events, not a full report or detailed filing.
2015-04-27 Chinese
关于公司非经营性资金占用及其他关联资金往来情况汇总表的专项审核报告
Audit Report / Information Classification · 95% confidence The document is titled as a "专项审核报告" which translates to a "special audit report" related to non-operating fund occupation and other related party fund transactions. It is a standalone audit report focusing on a specific audit area, not a full annual report or general financial statement. The document length is short (373 characters), but it contains a specific audit report rather than an announcement or certification. Therefore, it fits the category of Audit Report / Information (AR). FY 2014
2015-04-27 Chinese
2014年年度报告
Annual Report Classification · 100% confidence The document is titled '2014 年年度报告' which translates to '2014 Annual Report'. It contains detailed financial data, including profit and loss statements, cash flow, balance sheet data, management discussion and analysis, risk disclosures, company background, and other comprehensive information typical of a full annual report. It also mentions the audit report by 瑞华会计师事务所 with an unqualified opinion, which is usually included in annual reports. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. Therefore, this document fits the definition of an Annual Report (10-K). FY 2014
2015-04-27 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.